Free for academic non-profit institutions. Other users need a Commercial license

Aliases for RPS6KA3 Gene

Aliases for RPS6KA3 Gene

  • Ribosomal Protein S6 Kinase A3 2 3 5
  • MAP Kinase-Activated Protein Kinase 1b 3 4
  • Insulin-Stimulated Protein Kinase 1 3 4
  • MAPK-Activated Protein Kinase 1b 3 4
  • Ribosomal S6 Kinase 2 3 4
  • MAPKAP Kinase 1b 3 4
  • S6K-Alpha-3 3 4
  • EC 2.7.11.1 4 61
  • MAPKAPK-1b 3 4
  • P90-RSK 3 3 4
  • MAPKAPK1B 3 4
  • Pp90RSK2 3 4
  • ISPK-1 3 4
  • RSK-2 3 4
  • RSK2 3 4
  • Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 3
  • Ribosomal Protein S6 Kinase, 90kD, Polypeptide 3 2
  • 90 KDa Ribosomal Protein S6 Kinase 3 4
  • Ribosomal Protein S6 Kinase Alpha-3 3
  • S6K-Alpha3 3
  • EC 2.7.11 61
  • P90-RSK2 3
  • P90RSK3 4
  • MRX19 3
  • ISPK1 4
  • HU-3 3
  • CLS 3
  • RSK 3

External Ids for RPS6KA3 Gene

Previous HGNC Symbols for RPS6KA3 Gene

  • MRX19
  • CLS

Previous GeneCards Identifiers for RPS6KA3 Gene

  • GC0XU990207
  • GC0XM018839
  • GC0XM019371
  • GC0XM019534
  • GC0XM019933
  • GC0XM020077
  • GC0XM020168
  • GC0XM017910

Summaries for RPS6KA3 Gene

Entrez Gene Summary for RPS6KA3 Gene

  • This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS). [provided by RefSeq, Jul 2008]

GeneCards Summary for RPS6KA3 Gene

RPS6KA3 (Ribosomal Protein S6 Kinase A3) is a Protein Coding gene. Diseases associated with RPS6KA3 include Coffin-Lowry Syndrome and Non-Syndromic X-Linked Intellectual Disability. Among its related pathways are Activated TLR4 signalling and IL-2 Pathway. GO annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is RPS6KA2.

UniProtKB/Swiss-Prot for RPS6KA3 Gene

  • Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at Ser-10, which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at Ser-9 and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at Ser-1798, which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3. Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1. Phosphorylates SOS1 at Ser-1134 and Ser-1161 that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at Ser-897, the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630).

Tocris Summary for RPS6KA3 Gene

  • Ribosomal S6 protein kinases (RSKs) are a family of protein serine/threonine kinases that regulate diverse cellular processes such as cellular growth, motility, survival and proliferation. The RSK family can be divided into two subfamilies, namely p90 RSK and p70 S6K.

Gene Wiki entry for RPS6KA3 Gene

No data available for PharmGKB "VIP" Summary , fRNAdb sequence ontologies and piRNA Summary for RPS6KA3 Gene

Genomics for RPS6KA3 Gene

Regulatory Elements for RPS6KA3 Gene

Enhancers for RPS6KA3 Gene
GeneHancer Identifier Enhancer Score Enhancer Sources Gene-Enhancer Score TSS distance (kb) Number of Genes Away Size (kb) Transcription Factor Binding Sites within enhancer Gene Targets for Enhancer
GH0XF020439 0.4 ENCODE 19.1 -173.3 -173317 0.9 RPS6KA3 ENSG00000283400 GC0XP020402
GH0XF020374 0.8 Ensembl ENCODE 17.8 -107.9 -107901 2.0 RARA GATA4 FOS CREM MIXL1 CEBPB MAFF ETV4 RCOR2 CEBPA RPS6KA3 CXorf23 GC0XP020402 ENSG00000283631
GH0XF020360 0.8 Ensembl ENCODE 16.2 -95.1 -95124 4.0 ELF3 ZFP64 ARID4B FEZF1 DMAP1 DNMT3B ZNF121 GATA4 ZNF366 SCRT2 RPS6KA3 CXorf23 ENSG00000283631 GC0XP020402
GH0XF020372 0.6 Ensembl 14.1 -105.8 -105801 1.0 ZBTB40 RPS6KA3 GC0XP020402 ENSG00000283631
GH0XF020378 1.3 Ensembl ENCODE 13.6 -111.4 -111441 1.0 RFX1 ESRRA CEBPB NFYC USF2 RFX5 JUND SCRT2 NFYB FOS RPS6KA3 GC0XP020402 ENSG00000283631
- Elite enhancer/Elite enhancer-gene association Download Table
Download GeneHancer data dump

Enhancers around RPS6KA3 on UCSC Golden Path with GeneCards custom track

Promoters for RPS6KA3 Gene
Ensembl Regulatory Elements (ENSRs) TSS Distance (bp) Size (bp) Binding Sites for Transcription Factors within promoters
ENSR00000476306 800 5000 HDGF ATF1 PKNOX1 SIN3A ARID4B FEZF1 ZNF48 ZNF2 YY1 GLIS2

Genomic Location for RPS6KA3 Gene

Chromosome:
X
Start:
20,149,911 bp from pter
End:
20,267,100 bp from pter
Size:
117,190 bases
Orientation:
Minus strand

Genomic View for RPS6KA3 Gene

Genes around RPS6KA3 on UCSC Golden Path with GeneCards custom track

Cytogenetic band:
RPS6KA3 Gene in genomic location: bands according to Ensembl, locations according to GeneLoc (and/or Entrez Gene and/or Ensembl if different)
Genomic Location for RPS6KA3 Gene
GeneLoc Logo Genomic Neighborhood Exon StructureGene Density

RefSeq DNA sequence for RPS6KA3 Gene

Proteins for RPS6KA3 Gene

  • Protein details for RPS6KA3 Gene (UniProtKB/Swiss-Prot)

    Protein Symbol:
    P51812-KS6A3_HUMAN
    Recommended name:
    Ribosomal protein S6 kinase alpha-3
    Protein Accession:
    P51812
    Secondary Accessions:
    • B2R9V4
    • Q4VAP3
    • Q59H26
    • Q5JPK8
    • Q7Z3Z7

    Protein attributes for RPS6KA3 Gene

    Size:
    740 amino acids
    Molecular mass:
    83736 Da
    Cofactor:
    Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
    Quaternary structure:
    • Forms a complex with either MAPK1/ERK2 or MAPK3/ERK1 in quiescent cells. Transiently dissociates following mitogenic stimulation (By similarity). Interacts with NFATC4, ETV1/ER81 and FGFR1.
    SequenceCaution:
    • Sequence=BAD92170.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};

    Three dimensional structures from OCA and Proteopedia for RPS6KA3 Gene

neXtProt entry for RPS6KA3 Gene

Post-translational modifications for RPS6KA3 Gene

  • Activated by phosphorylation at Ser-227 by PDPK1. Autophosphorylated on Ser-386, as part of the activation process. May be phosphorylated at Thr-365 and Ser-369 by MAPK1/ERK2 and MAPK3/ERK1. Can also be activated via phosphorylation at Ser-386 by MAPKAPK2.
  • N-terminal myristoylation results in an activated kinase in the absence of added growth factors.
  • Ubiquitination at Lys 81
  • Modification sites at PhosphoSitePlus

Antibody Products

  • Cell Signaling Technology (CST) Antibodies for RPS6KA3 (RSK2)

Domains & Families for RPS6KA3 Gene

Graphical View of Domain Structure for InterPro Entry

P51812

UniProtKB/Swiss-Prot:

KS6A3_HUMAN :
  • Contains 1 AGC-kinase C-terminal domain.
  • Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. S6 kinase subfamily.
Domain:
  • Contains 1 AGC-kinase C-terminal domain.
  • Contains 2 protein kinase domains.
Family:
  • Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. S6 kinase subfamily.
genes like me logo Genes that share domains with RPS6KA3: view

Function for RPS6KA3 Gene

Molecular function for RPS6KA3 Gene

GENATLAS Biochemistry:
ribosomal S6 kinase,polypeptide 3,growth factor regulated serine /threonine kinase family,responsive for the activation of glycogen synthesis,involved in cell proliferation and differentiation but not in vivo in the phosphorylation of RPS6,mediating protein synthesis initiation and elongation induced by hormones or growth factors,maybe playing an essentilal regulatory role in protein synthesis during cell proliferation,required for epidermal growth factor activated phosphorylation of histone H3
UniProtKB/Swiss-Prot CatalyticActivity:
ATP + a protein = ADP + a phosphoprotein.
UniProtKB/Swiss-Prot EnzymeRegulation:
Upon extracellular signal or mitogen stimulation, phosphorylated at Thr-577 in the C-terminal kinase domain (CTKD) by MAPK1/ERK2 and MAPK3/ERK1. The activated CTKD then autophosphorylates Ser-386, allowing binding of PDPK1, which in turn phosphorylates Ser-227 in the N-terminal kinase domain (NTDK) leading to the full activation of the protein and subsequent phosphorylation of the substrates by the NTKD.
UniProtKB/Swiss-Prot Function:
Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at Ser-10, which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at Ser-9 and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at Ser-1798, which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3. Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1. Phosphorylates SOS1 at Ser-1134 and Ser-1161 that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at Ser-897, the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630).

Enzyme Numbers (IUBMB) for RPS6KA3 Gene

Gene Ontology (GO) - Molecular Function for RPS6KA3 Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0000287 magnesium ion binding IEA --
GO:0004672 protein kinase activity IEA,TAS 10436156
GO:0004674 protein serine/threonine kinase activity IEA,TAS --
GO:0005515 protein binding IPI 21988832
GO:0005524 ATP binding IEA --
genes like me logo Genes that share ontologies with RPS6KA3: view
genes like me logo Genes that share phenotypes with RPS6KA3: view

Human Phenotype Ontology for RPS6KA3 Gene

HPO Id HPO Name Alternative Ids Definition Synonyms

Animal Models for RPS6KA3 Gene

MGI Knock Outs for RPS6KA3:

Animal Model Products

Inhibitory RNA Products

Flow Cytometry Products

No data available for Transcription Factor Targets and HOMER Transcription for RPS6KA3 Gene

Localization for RPS6KA3 Gene

Subcellular locations from UniProtKB/Swiss-Prot for RPS6KA3 Gene

Nucleus. Cytoplasm.

Subcellular locations from

COMPARTMENTS
Jensen Localization Image for RPS6KA3 Gene COMPARTMENTS Subcellular localization image for RPS6KA3 gene
Compartment Confidence
cytosol 5
nucleus 5
mitochondrion 2
cytoskeleton 1
extracellular 1
golgi apparatus 1
plasma membrane 1

Gene Ontology (GO) - Cellular Components for RPS6KA3 Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0005634 nucleus IEA,IBA --
GO:0005654 nucleoplasm TAS --
GO:0005737 cytoplasm IEA,IBA --
GO:0005829 cytosol TAS --
genes like me logo Genes that share ontologies with RPS6KA3: view

Pathways & Interactions for RPS6KA3 Gene

SuperPathways for RPS6KA3 Gene

SuperPathway Contained pathways
1 Activated TLR4 signalling
2 Post NMDA receptor activation events
3 Nuclear Events (kinase and transcription factor activation)
4 GDNF-Family Ligands and Receptor Interactions
5 Apoptotic Pathways in Synovial Fibroblasts
genes like me logo Genes that share pathways with RPS6KA3: view

SIGNOR curated interactions for RPS6KA3 Gene

Activates:
Inactivates:
Is activated by:
Is inactivated by:
Other effect:

Gene Ontology (GO) - Biological Process for RPS6KA3 Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0001501 skeletal system development TAS 8955270
GO:0002224 toll-like receptor signaling pathway IEA,ISS --
GO:0006468 protein phosphorylation IEA --
GO:0006915 apoptotic process IEA --
GO:0007049 cell cycle IEA --
genes like me logo Genes that share ontologies with RPS6KA3: view

Drugs & Compounds for RPS6KA3 Gene

(21) Drugs for RPS6KA3 Gene - From: DrugBank, ApexBio, DGIdb, HMDB, Tocris, and Novoseek

Name Status Disease Links Group Role Mechanism of Action Clinical Trials
Aspirin Approved, Vet_approved Pharma Channel blocker, Target 1112
Adenosine triphosphate Approved Nutra 0
AT9283 Investigational Pharma inhibitor Aurora kinase/JAK inhibitor, Kinase Inhibitors, Inhibitors of mitosis Aurora kinase inhibitors 0
BRD 7389 Pharma P90 RSK inhibitor, Ribosomal S6 kinase inhibitor 0
PF-4708671 Pharma P70 S6K1 isoform inhibitor,cell-permeable, S6K1 inhibitor 0

(4) Additional Compounds for RPS6KA3 Gene - From: Novoseek and HMDB

Name Synonyms Role CAS Number PubChem IDs PubMed IDs
ADP
  • Adenosindiphosphorsaeure
  • Adenosine 5'-pyrophosphate
  • Adenosine diphosphate
  • Adenosine pyrophosphate
  • Adenosine-5'-diphosphate
Full agonist, Agonist 58-64-0

(3) Tocris Compounds for RPS6KA3 Gene

Compound Action Cas Number
BRD 7389 Ribosomal S6 kinase inhibitor 376382-11-5
PF 4708671 S6K1 inhibitor 1255517-76-0
SL 0101-1 Selective ribosomal S6 kinase (RSK) inhibitor 77307-50-7

(6) ApexBio Compounds for RPS6KA3 Gene

Compound Action Cas Number
BI-D1870 P90 RSK inhibitor,ATP-competitive and cell-permeable 501437-28-1
BIX 02565 RSK2 inhibitor 1311367-27-7
BRD 7389 P90 RSK inhibitor 376382-11-5
CMK RSK2 kinase inhibitor 821794-90-5
PF-4708671 P70 S6K1 isoform inhibitor,cell-permeable 1255517-76-0
SL 0101-1 77307-50-7
genes like me logo Genes that share compounds with RPS6KA3: view

Drug Products

Transcripts for RPS6KA3 Gene

Unigene Clusters for RPS6KA3 Gene

Ribosomal protein S6 kinase, 90kDa, polypeptide 3:
Representative Sequences:

Inhibitory RNA Products

Flow Cytometry Products

Alternative Splicing Database (ASD) splice patterns (SP) for RPS6KA3 Gene

ExUns: 1 ^ 2 ^ 3a · 3b ^ 4 ^ 5a · 5b ^ 6 ^ 7 ^ 8 ^ 9 ^ 10 ^ 11 ^ 12 ^ 13 ^ 14 ^ 15 ^ 16 ^ 17 ^ 18 ^ 19 ^ 20 ^ 21 ^ 22 ^ 23a · 23b
SP1: - - -
SP2: - - -
SP3: -
SP4:

Relevant External Links for RPS6KA3 Gene

GeneLoc Exon Structure for
RPS6KA3
ECgene alternative splicing isoforms for
RPS6KA3

Expression for RPS6KA3 Gene

mRNA expression in normal human tissues for RPS6KA3 Gene

mRNA differential expression in normal tissues according to GTEx for RPS6KA3 Gene

This gene is overexpressed in Muscle - Skeletal (x4.0).

Protein differential expression in normal tissues from HIPED for RPS6KA3 Gene

This gene is overexpressed in Lymph node (16.4) and Peripheral blood mononuclear cells (12.4).

Integrated Proteomics: protein expression in normal tissues and cell lines from ProteomicsDB, PaxDb, MaxQB, and MOPED for RPS6KA3 Gene



Protein tissue co-expression partners for RPS6KA3 Gene

- Elite partner

NURSA nuclear receptor signaling pathways regulating expression of RPS6KA3 Gene:

RPS6KA3

SOURCE GeneReport for Unigene cluster for RPS6KA3 Gene:

Hs.445387

mRNA Expression by UniProt/SwissProt for RPS6KA3 Gene:

P51812-KS6A3_HUMAN
Tissue specificity: Expressed in many tissues, highest levels in skeletal muscle.
genes like me logo Genes that share expression patterns with RPS6KA3: view

Primer Products

No data available for mRNA expression in embryonic tissues and stem cells from LifeMap Discovery for RPS6KA3 Gene

Orthologs for RPS6KA3 Gene

This gene was present in the common ancestor of eukaryotes.

Orthologs for RPS6KA3 Gene

Organism Taxonomy Gene Similarity Type Details
oppossum
(Monodelphis domestica)
Mammalia RPS6KA3 35
  • 99 (a)
OneToOne
chimpanzee
(Pan troglodytes)
Mammalia RPS6KA3 34
  • 96.66 (n)
dog
(Canis familiaris)
Mammalia RPS6KA3 34 35
  • 95.93 (n)
cow
(Bos Taurus)
Mammalia RPS6KA3 34 35
  • 95.77 (n)
rat
(Rattus norvegicus)
Mammalia Rps6ka3 34
  • 94.95 (n)
mouse
(Mus musculus)
Mammalia Rps6ka3 34 16 35
  • 94.41 (n)
platypus
(Ornithorhynchus anatinus)
Mammalia RPS6KA3 35
  • 67 (a)
OneToOne
chicken
(Gallus gallus)
Aves RPS6KA3 34 35
  • 86.43 (n)
lizard
(Anolis carolinensis)
Reptilia RPS6KA3 35
  • 97 (a)
OneToOne
tropical clawed frog
(Silurana tropicalis)
Amphibia LOC100496161 34
  • 79.63 (n)
African clawed frog
(Xenopus laevis)
Amphibia Xl.33175 34
zebrafish
(Danio rerio)
Actinopterygii rps6ka3a 35
  • 86 (a)
OneToMany
rps6ka3b 34 35
  • 73.83 (n)
Dr.21039 34
African malaria mosquito
(Anopheles gambiae)
Insecta AgaP_AGAP003040 34
  • 59.08 (n)
fruit fly
(Drosophila melanogaster)
Insecta S6kII 36 34 35
  • 57.85 (n)
Pk17E 36
  • 42 (a)
worm
(Caenorhabditis elegans)
Secernentea T01H8.1b 36
  • 62 (a)
rskn-1 35
  • 56 (a)
OneToMany
R04A9.5 36
  • 41 (a)
F28C10.3 36
  • 36 (a)
soybean
(Glycine max)
eudicotyledons Gma.3835 34
Alicante grape
(Vitis vinifera)
eudicotyledons Vvi.5313 34
barley
(Hordeum vulgare)
Liliopsida Hv.12219 34
rice
(Oryza sativa)
Liliopsida Os.11068 34
sea squirt
(Ciona savignyi)
Ascidiacea -- 35
  • 71 (a)
OneToMany
sea squirt
(Ciona intestinalis)
Ascidiacea Cin.8096 34
Species where no ortholog for RPS6KA3 was found in the sources mined by GeneCards:
  • A. gosspyii yeast (Ashbya gossypii)
  • Actinobacteria (Mycobacterium tuberculosis)
  • alpha proteobacteria (Wolbachia pipientis)
  • amoeba (Dictyostelium discoideum)
  • Archea (Pyrococcus horikoshii)
  • baker's yeast (Saccharomyces cerevisiae)
  • beta proteobacteria (Neisseria meningitidis)
  • bread mold (Neurospora crassa)
  • Chromalveolata (Phytophthora infestans)
  • common water flea (Daphnia pulex)
  • corn (Zea mays)
  • E. coli (Escherichia coli)
  • filamentous fungi (Aspergillus nidulans)
  • Firmicute bacteria (Streptococcus pneumoniae)
  • fission yeast (Schizosaccharomyces pombe)
  • green algae (Chlamydomonas reinhardtii)
  • honey bee (Apis mellifera)
  • K. lactis yeast (Kluyveromyces lactis)
  • loblloly pine (Pinus taeda)
  • malaria parasite (Plasmodium falciparum)
  • medicago trunc (Medicago Truncatula)
  • moss (Physcomitrella patens)
  • orangutan (Pongo pygmaeus)
  • pig (Sus scrofa)
  • rainbow trout (Oncorhynchus mykiss)
  • rice blast fungus (Magnaporthe grisea)
  • schistosome parasite (Schistosoma mansoni)
  • sea anemone (Nematostella vectensis)
  • sea urchin (Strongylocentrotus purpuratus)
  • sorghum (Sorghum bicolor)
  • stem rust fungus (Puccinia graminis)
  • sugarcane (Saccharum officinarum)
  • thale cress (Arabidopsis thaliana)
  • tomato (Lycopersicon esculentum)
  • toxoplasmosis (Toxoplasma gondii)
  • Trichoplax (Trichoplax adhaerens)
  • wheat (Triticum aestivum)

Evolution for RPS6KA3 Gene

ENSEMBL:
Gene Tree for RPS6KA3 (if available)
TreeFam:
Gene Tree for RPS6KA3 (if available)

Paralogs for RPS6KA3 Gene

genes like me logo Genes that share paralogs with RPS6KA3: view

Variants for RPS6KA3 Gene

Sequence variations from dbSNP and Humsavar for RPS6KA3 Gene

SNP ID Clin Chr 0X pos Sequence Context AA Info Type
rs122454124 Coffin-Lowry syndrome (CLS) [MIM:303600], Pathogenic 20,209,307(-) ATTAG(G/T)GCAGG reference, missense
rs122454125 Coffin-Lowry syndrome (CLS) [MIM:303600], Pathogenic 20,187,923(-) CATAT(G/T)CTTTT reference, missense
rs122454126 Coffin-Lowry syndrome (CLS) [MIM:303600], Pathogenic 20,204,103(-) TGCAG(G/T)TTTTC reference, missense
rs122454127 Coffin-Lowry syndrome (CLS) [MIM:303600], Pathogenic 20,195,131(-) GAGTT(C/T)GGACA reference, missense
rs122454129 Mental retardation, X-linked 19 (MRX19) [MIM:300844], Pathogenic 20,175,244(-) TTTTT(C/T)GGGGG reference, missense

Structural Variations from Database of Genomic Variants (DGV) for RPS6KA3 Gene

Variant ID Type Subtype PubMed ID
esv2672797 CNV deletion 23128226
esv3558672 CNV deletion 23714750
esv3576795 CNV gain 25503493
nsv478641 CNV novel sequence insertion 20440878
nsv520690 CNV gain 19592680
nsv526033 CNV gain 19592680

Variation tolerance for RPS6KA3 Gene

Residual Variation Intolerance Score: 54.3% of all genes are more intolerant (likely to be disease-causing)
Gene Damage Index Score: 1.35; 26.76% of all genes are more intolerant (likely to be disease-causing)

Relevant External Links for RPS6KA3 Gene

Human Gene Mutation Database (HGMD)
RPS6KA3
SNPedia medical, phenotypic, and genealogical associations of SNPs for
RPS6KA3

No data available for Polymorphic Variants from UniProtKB/Swiss-Prot for RPS6KA3 Gene

Disorders for RPS6KA3 Gene

MalaCards: The human disease database

(5) MalaCards diseases for RPS6KA3 Gene - From: OMIM, ClinVar, GeneTests, Orphanet, Swiss-Prot, DISEASES, Novoseek, and GeneCards

Disorder Aliases PubMed IDs
coffin-lowry syndrome
  • mental retardation with osteocartilaginous abnormalities
non-syndromic x-linked intellectual disability
  • mrx
partington syndrome
  • partington x-linked mental retardation syndrome
hemorrhoid
  • hemorrhoidal disease
x-linked disease
- elite association - COSMIC cancer census association via MalaCards

UniProtKB/Swiss-Prot

KS6A3_HUMAN
  • Coffin-Lowry syndrome (CLS) [MIM:303600]: A X-linked mental retardation associated with facial and digital dysmorphisms, progressive skeletal malformations, growth retardation, hearing deficit and paroxysmal movement disorders. {ECO:0000269 PubMed:10094187, ECO:0000269 PubMed:10528858, ECO:0000269 PubMed:14986828, ECO:0000269 PubMed:15214012, ECO:0000269 PubMed:8955270, ECO:0000269 PubMed:9837815}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Mental retardation, X-linked 19 (MRX19) [MIM:300844]: A non-syndromic form of mild to moderate mental retardation. Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. In contrast to syndromic or specific X-linked mental retardation which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation. {ECO:0000269 PubMed:10319851, ECO:0000269 PubMed:17100996}. Note=The disease is caused by mutations affecting the gene represented in this entry.

Relevant External Links for RPS6KA3

Genetic Association Database (GAD)
RPS6KA3
Human Genome Epidemiology (HuGE) Navigator
RPS6KA3
Atlas of Genetics and Cytogenetics in Oncology and Haematology:
RPS6KA3
genes like me logo Genes that share disorders with RPS6KA3: view

No data available for Genatlas for RPS6KA3 Gene

Publications for RPS6KA3 Gene

  1. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. (PMID: 8955270) Trivier E. … Hanauer A. (Nature 1996) 3 4 22 46 64
  2. Human rsk isoforms: cloning and characterization of tissue-specific expression. (PMID: 8141249) Moller D.E. … Jakubowski M. (Am. J. Physiol. 1994) 2 3 4 22 64
  3. RSK2 mediates muscle cell differentiation through regulation of NFAT3. (PMID: 17213202) Cho Y.-Y. … Dong Z. (J. Biol. Chem. 2007) 3 4 22 64
  4. Identification of novel mutations in the RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. (PMID: 16879200) Delaunoy J.P. … Hanauer A. (Clin. Genet. 2006) 2 3 22 64
  5. Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. (PMID: 16223362) Wingate A.D. … Arthur J.S. (Biochem. J. 2006) 3 4 22 64

Products for RPS6KA3 Gene

Sources for RPS6KA3 Gene

Content
Loading form....